Myriad Genetics MYGN Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $126M+24.8% | $151.3M+35.2% | $154.8M+41.0% | $83.7M-17.3% | $101M-4.4% | ||
| $123.8M+2.8% | $115.3M-4.9% | $118M-6.1% | $137M+16.3% | $120.4M+1.9% | ||
| $27.9M-1.4% | $30.6M+11.3% | $31.6M+20.6% | $28.7M+10.0% | $28.3M+15.0% | ||
| $312.8M+8.9% | $332.6M+11.6% | $344.8M+17.6% | $284.3M-2.5% | $287.2M-1.1% | ||
| $111.5M-2.2% | $114M-2.9% | $111.4M-3.5% | $113M-2.8% | $114M-3.8% | ||
| $47.1M-83.5% | $51.6M-82.0% | $51.6M-82.0% | $51.6M-82.0% | $286.3M-0.2% | ||
| $145.7M-43.4% | $153.4M-41.5% | $163.1M-47.8% | $170.1M-46.8% | $257.5M-24.5% | ||
| $673.7M-33.0% | $706.6M-31.2% | $728.1M-32.7% | $677.3M-37.6% | $1.01B-9.4% | ||
| $32.6M+16.0% | $30M-7.1% | $31.8M+7.4% | $30.9M-7.2% | $28.1M-15.1% | ||
| $130.2M-13.8% | $133.8M-18.5% | $148M-4.1% | $199.9M+34.3% | $151.1M+3.4% | ||
| $120.3M+103% | $119.9M+203% | $119.5M+206% | $0-100% | $59.3M+53.2% | ||
| $336.3M+11.7% | $338.6M+3.7% | $355.3M+1.6% | $289.2M-16.1% | $301.2M-14.1% | ||
| 150M0.0% | 900K0.0% | 150M0.0% | 150M0.0% | 150M0.0% | ||
| -$1.16B-52.8% | -$1.12B-48.3% | -$1.11B-56.1% | -$1.09B-57.1% | -$756.9M-15.5% | ||
| $337.4M-52.1% | $368M-47.5% | $372.8M-49.1% | $388.1M-47.6% | $704.9M-7.2% | ||
| $673.7M-33.0% | $706.6M-31.2% | $728.1M-32.7% | $677.3M-37.6% | $1.01B-9.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Myriad Genetics's total assets?
- Myriad Genetics (MYGN) holds $673.7M in total assets, down 33.0% year over year.
- How much debt does Myriad Genetics have?
- Myriad Genetics carries $211.5M in total debt against $337.4M of shareholders' equity, a debt-to-equity ratio of 0.63.
- How much cash does Myriad Genetics have?
- Myriad Genetics holds $126.0M in cash and equivalents.
- Can Myriad Genetics cover its short-term obligations?
- Its current ratio is 2.40 — current assets exceed current liabilities.
- Where does Myriad Genetics's balance sheet data come from?
- Every line is extracted from Myriad Genetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
